会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Substituted oximes and hydrazones as neurokinin antagonists
    • 取代的肟和腙作为神经激肽拮抗剂
    • US06403582B2
    • 2002-06-11
    • US09759045
    • 2001-01-12
    • Gregory A. ReichardNeng-Yang ShihDasong Wang
    • Gregory A. ReichardNeng-Yang ShihDasong Wang
    • C07D23504
    • C07D401/04C07D401/06C07D401/14C07D403/06
    • Compound represented by the structural formula or a pharmaceutically acceptable salt thereof, wherein: a is 0-3; b, d and e are 0-2; R is H, alkyl, F or —OR6; A is an optionally substituted oxime or hydrazone; d is not 0 and X is a bond, —C(O)—, —O—, —NR9—, —S(O)e—, —N(R6)C(O)—, —C(O)N(R6)—, —OC(O)NR6—, —OC(═S)NR6—, —N(R6)C(═S)O—, —S(O)2N(R6)—, —N(R6)S(O)2—, —N(R6)C(O)O—, —OC(O)— or —N(R6)C(O)NR7—; or d is 0 and X is a bond or —NR6—; T is H, aryl, heterocycloalkyl or heteroaryl; Q is phenyl, naphthyl or heteroaryl; R6 is H, alkyl, hydroxyalkyl, alkoxyalkyl, phenyl, and benzyl; R9 is R6 or —OR6 R6a, R7a, R8a and R9a are H or alkyl; Z is a nitrogen-containing heterocyclo group, e.g., piperidinyl, substituted by a heterocyclo- or heterocycloalkyl group; wherein phenyl, benzyl, aryl, heterocycloalkyl, heteroaryl and cycloalkyl groups are optionally substituted; methods of treating diseases such as asthma, cough, bronchospasm, depression, emesis, imflammatory diseases, and gastrointestinal disorders with said compounds, and pharmaceutical compositions comprising said compounds are disclosed.
    • 由结构式表示的化合物或其药学上可接受的盐,其中:a为0-3; b,d和e为0-2; R为H,烷基,F或-OR 6; A为任选取代的肟或腙; (O) - , - O - , - NR9 - , - S(O)e - , - N(R6)C(O) - , - (O) (R6) - , - OC(O)NR6-,-OC(= S)NR6-,-N(R6)C(= S)O-,-S(O) )S(O)2 - , - N(R 6)C(O)O-,-OC(O) - 或-N(R 6)C(O)NR 7 - 或者d是0,X是一个键或-NR6-; T是H,芳基,杂环烷基或杂芳基; Q是苯基,萘基或杂芳基; R6是H,烷基,羟基烷基,烷氧基烷基,苯基和苄基; R9是R6 或-OR6R6a,R7a,R8a和R9a是H或烷基; Z是含氮杂环基,例如被杂环基或杂环烷基取代的哌啶基;其中苯基,苄基,芳基,杂环烷基,杂芳基和环烷基是 任选取代; 公开了用所述化合物治疗哮喘,咳嗽,支气管痉挛,抑郁症,呕吐,炎性疾病和胃肠道疾病等疾病的方法,以及包含所述化合物的药物组合物。
    • 7. 发明授权
    • Substituted oximes and hydrazones as neurokinin antagonists
    • 取代的肟和腙作为神经激肽拮抗剂
    • US06204265B1
    • 2001-03-20
    • US09468591
    • 1999-12-21
    • Gregory A. ReichardNeng-Yang ShihDasong Wang
    • Gregory A. ReichardNeng-Yang ShihDasong Wang
    • C07D23904
    • C07D401/04C07D401/06C07D401/14C07D403/06
    • Compound represented by the structural formula or a pharmaceutically acceptable salt thereof, wherein: a is 0-3; b, d and e are 0-2; R is H, alkyl, F or —OR6; A is an optionally substituted oxime or hydrazone; d is not 0 and X is a bond, —C(O)—, —O—, —NR9—, —S(O)e—, —N(R6)C(O)—, —C(O)N(R6)—, —OC(O)NR6—, —OC(═S)NR6—, —N(R6)C(═S)O—, —S(O)2N(R6)—, —N(R6)S(O)2—, —N(R6)C(O)O—, —OC(O)— or —N(R6)C(O)NR7—; or d is 0 and X is a bond or —NR6—; T is H, aryl, heterocycloalkyl or heteroaryl; Q is phenyl, naphthyl or heteroaryl; R6 is H, alkyl, hydroxyalkyl, alkoxyalkyl, phenyl, and benzyl; R9 is R6 or —OR6 R6a, R7a, R8a and R9a are H or alkyl; Z is a nitrogen-containing heterocyclo group, e.g., piperidinyl, substituted by a heterocyclo- or heterocycloalkyl group; wherein phenyl, benzyl, aryl, heterocycloalkyl, heteroaryl and cycloalkyl groups are optionally substituted; methods of treating diseases such as asthma, cough, bronchospasm, depression, emesis, imflammatory diseases, and gastrointestinal disorders with said compounds, and pharmaceutical compositions comprising said compounds are disclosed.
    • 由结构式表示的化合物或其药学上可接受的盐,其中:a为0-3; b,d和e为0-2; R为H,烷基,F或-OR 6; A为任选取代的肟或腙; (O) - , - O - , - NR9 - , - S(O)e - , - N(R6)C(O) - , - (O) (R6) - , - OC(O)NR6-,-OC(= S)NR6-,-N(R6)C(= S)O-,-S(O) )S(O)2 - , - N(R 6)C(O)O-,-OC(O) - 或-N(R 6)C(O)NR 7 - 或者d是0,X是一个键或-NR6-; T是H,芳基,杂环烷基或杂芳基; Q是苯基,萘基或杂芳基; R6是H,烷基,羟基烷基,烷氧基烷基,苯基和苄基; R9是R6 或-OR6R6a,R7a,R8a和R9a是H或烷基; Z是含氮杂环基,例如被杂环基或杂环烷基取代的哌啶基;其中苯基,苄基,芳基,杂环烷基,杂芳基和环烷基是 任选取代; 公开了用所述化合物治疗哮喘,咳嗽,支气管痉挛,抑郁症,呕吐,炎性疾病和胃肠道疾病等疾病的方法,以及包含所述化合物的药物组合物。